Thalidomide before autologous stem cell transplantation in VAD-refractory multiple myeloma patients.
Francesca
F
Patriarca
Alessandra
A
Sperotto
Simonetta
S
Prosdocimo
Antonella
A
Geromin
Francesco
F
Zaja
Renato
R
Fanin
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D003561:Cytarabine; D003907:Dexamethasone; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000175:diagnosis / Q000188:drug therapy* / Q000628:therapy*; D036102:Peripheral Blood Stem Cell Transplantation; D033581:Stem Cell Transplantation; D013792:Thalidomide / Q000627:therapeutic use*; D014750:Vincristine
D003561:Cytarabine; D013792:Thalidomide; D014750:Vincristine; D003907:Dexamethasone